Acquisitions and Dispositions (Tables)

6 Months Ended

Jun. 30, 2012

Acquisitions and Dispositions Disclosure

Schedule of Purchase Price Allocation [Table Text Block]

(In millions)			Doe & Ingalls
Purchase Price
	Cash paid		$	173.8
	Purchase price payable			1.0
	Fair value of contingent consideration			1.5
			$	176.3
Net Assets Acquired
	Current assets		$	21.7
	Property, plant and equipment			11.6
	Intangible assets:
		Customer relationships		68.2
		Product technology		1.1
		Tradenames and other		16.8
	Goodwill			81.3
	Other assets			0.4
	Liabilities assumed			(24.8)
			$	176.3

Business Acquisition, Pro Forma Information [Table Text Block]

The company acquired Dionex Corporation in May 2011 and the Phadia group in August 2011. Had the acquisitions of Dionex and Phadia been completed as of the beginning of 2010, the company's pro forma results for 2011 would have been as follows:

		Three Months		Six Months
		Ended		Ended
(In millions except per share amounts)		July 2, 2011		July 2, 2011
Revenues		$	3,064.2	$	6,012.9
Income from Continuing Operations		$	255.6	$	520.8
Net Income		$	561.9	$	831.8
Earnings per Share from Continuing Operations:
	Basic	$	0.67	$	1.35
	Diluted	$	0.66	$	1.33
Earnings per Share:
	Basic	$	1.47	$	2.16
	Diluted	$	1.46	$	2.13

Pro forma results include non-recurring pro forma adjustments that were directly attributable to the business combinations including a pre-tax reduction in revenue of $0.1 million and $1.2million in the three and six months ended July 2, 2011, respectively, due to the impact of revaluing Dionex deferred revenue obligations to fair value.

       Additionally, the following non-recurring pro forma adjustments relating to charges recorded in 2011 have been assumed to have occurred in 2010 for pro forma purposes:

•        Pre-tax increase in income of $21.6 million for the three and six months ended July 2, 2011, relating to monetizing equity awards held by Dionex employees at the date of acquisition.
•        Pre-tax increase in income of $14.5 million for the three and six months ended July 2, 2011, for the sale of Dionex inventories revalued at the date of acquisition.
•        Pre-tax increase in income of $59.9 million and $62.9 million in the three andsix months ended July 2, 2011, respectively, for acquisition-related transaction costs incurred by both the company and the acquirees.

Schedule of Disposal Groups, Including Discontinued Operations, Income Statement, Balance Sheet and Additional Disclosures [Table Text Block]

Dispositions

       On April 4, 2011, the company sold, in separate transactions, its Athena Diagnostics business for $740 million in cash and its Lancaster Laboratories business for $180 million in cash and escrowed proceeds of $20 million, due in October 2012. The sale of these businesses resulted in an after-tax gain of approximately $304 million or $0.79 per diluted share in the second quarter of 2011. The results of both businesses have been included in the accompanying financial statements as discontinued operations. Operating results of these businessesin the first quarter of 2011 were as follows:

(In millions)	2011
Revenues	$	54.3
Pre-tax Income		9.1

       Operating results of the laboratory workstations business were as follows:

	Three Months Ended					Six Months Ended
	June 30,		July 2,			June 30,		July 2,
(In millions)	2012			2011		2012			2011
Revenues	$	46.4		$	46.8	$	94.3		$	87.7
Pre-tax Income (Loss)		(12.4)			0.8		(18.5)			0.3